Search Results
14 items found for "IL-33R"
- Sweet taste receptor agonists attenuate macrophage IL‐1β expression and eosinophilic inflammation...
September 2022 Sweet taste receptor agonists attenuate macrophage IL‐1β expression and eosinophilic inflammation Autophagy deficiency in myeloid cells plays a causal role in eosinophilic CRS (ECRS) via macrophage IL autophagy‐enhancing agent, trehalose, or related sugar compounds, and the underlying mechanism focusing on macrophage IL Methods We investigated the therapeutic effects of trehalose and saccharin on macrophage IL‐1β production
- Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent skin...
Activation of Mrgpra2 by defensin triggered neutrophil release of IL-1β and CXCL2 which are vital for
- β2-Adrenergic Receptor Expression and Intracellular Signaling in B Cells Are Highly Dynamic during..
phosphorylation of p38 MAPK, ERK1/2 and CREB in the late phase of arthritis was associated with increased IL
- Constitutive, Basal, and β-Alanine-Mediated Activation of the Human Mas-Related G Protein-Coupled ..
of the Human Mas-Related G Protein-Coupled Receptor D Induces Release of the Inflammatory Cytokine IL G-protein coupled receptor D (MRGPRD) in the regulation of the inflammatory mediator interleukin 6 (IL stimulating human MRGPRD-expressing HeLa cells with the agonist β-alanine, we observed a release of IL IkB kinases (IKK)-mediated canonical activation of nuclear factor kappa-B (NF-κB) and stimulation of IL This IL-6 release could be blocked by a Gαq inhibitor (YM-254890), an IKK complex inhibitor (IKK-16),
- Chronic itch: emerging treatments following new research concepts
Currently, inhibitors of IL-31, IL-4/13, NK1 receptors, opioids and cannabinoids, JAK, PDE4 or TRP are
- TAS2R supports odontoblastic differentiation of human dental pulp stem cells in the inflammatory...
tissues from the patients. hDPSCs isolated from the healthy pulp tissues were stimulated by LPS, TNFα and IL
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
October 2022 "CXCR1 and CXCR2 chemokine receptors, mainly activated by interleukin 8 (IL-8 or CXCL8),
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
August 2022 "CXCR1 and CXCR2 chemokine receptors, mainly activated by interleukin 8 (IL-8 or CXCL8),
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
personalized cancer therapy GPR97 depletion aggravates imiquimod-induced psoriasis pathogenesis via amplifying IL -23/IL-17 axis signal pathway Structural and Molecular Insights into GPCR Function Exploring the constitutive
- 📰 GPCR Weekly News, June 12 to 18, 2023
Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production
- 📰 GPCR Weekly News, May 15 to 21, 2023
ACE2 Activation by Tripeptide IRW (Ile-Arg-Trp) Depends on the G Protein-Coupled Receptor 30 Signaling
- 📰 GPCR Weekly News, June 19 to 25, 2023
and Signaling Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL
- 📰 GPCR Weekly News, November 13 to 19, 2023
GPCR CD97: Filling in some of the gaps GPCR Activation and Signaling Butyrate induces STAT3/HIF-1α/IL
- 📰 GPCR Weekly News, May 29 to June 4, 2023
GPCR Binders, Drugs, and more ACE2 Activation by Tripeptide IRW (Ile-Arg-Trp) Depends on the G Protein-Coupled